logo
Select company
Select metric
$ -45KNet Cash Flow - Issuance (Purchase) of Equity Shares
VS
Market
57
Sector
83
Industry
95
History
100
$ 4.18Close
$ 1.25 - $ 4.32 52-Week Range
Ticker Information

Ticker

BDTX

Company Name

BLACK DIAMOND THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

BLACK DIAMOND THERAPEUTICS INC - Net Cash Flow - Issuance (Purchase) of Equity Shares Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

BDTX - CF - Equity Historical data
DateNet Cash Flow - Issuance (Purchase) of Equity Shares
6/30/2025$ -45K
3/31/2025$ 21.45M
12/31/2024$ 25.55M
9/30/2024$ 25.21M
6/30/2024$ 97.39M
3/31/2024$ 76.01M
12/31/2023$ 71.93M
9/30/2023$ 71.95M
6/30/2023$ 75K
3/31/2023$ 75K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • BLACK DIAMOND THERAPEUTICS INC's latest trailing twelve months (TTM) CF - Equity stands at $ 214.11M.
  • Over the past 5 years, BLACK DIAMOND THERAPEUTICS INC's average CF - Equity has been $ 41.26M.
  • The median CF - Equity for BLACK DIAMOND THERAPEUTICS INC during this period was $ 1.67M
  • BLACK DIAMOND THERAPEUTICS INC reached its highest CF - Equity over the past 5 years at $ 214.94M.
  • The lowest CF - Equity recorded by BLACK DIAMOND THERAPEUTICS INC in the same timeframe $ -45K

BLACK DIAMOND THERAPEUTICS INC's CF - Equity vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Equity Benchmarks
CompanyCF - Equity
PLX : PROTALIX BIOTHERAPEUTICS INC $ 12.81MTHTX : THERATECHNOLOGIES INC -SGMO : SANGAMO THERAPEUTICS INC $ 46.61MALEC : ALECTOR INC $ 1.04MCSBR : CHAMPIONS ONCOLOGY INC $ 344KENTA : ENANTA PHARMACEUTICALS INC $ 162KSPRO : SPERO THERAPEUTICS INC $ 0AGEN : AGENUS INC $ 32.82MCELU : CELULARITY INC $ 3.53MIVVD : INVIVYD INC $ 518K

Definition of Net Cash Flow - Issuance (Purchase) of Equity Shares

[Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).

BDTX - Net Cash Flow - Issuance (Purchase) of Equity Shares, Last 5 years

$ -45K

Minimum

Jun 30, 2025

$ 214.94M

Maximum

Dec 31, 2020

$ 41.26M

Average

$ 1.67M

Median

CF - Equity Benchmark Analysis

The chart above depicts the distribution of CF - Equity for companies in the Total Stock Market. The average CF - Equity of the companies is $ 130.54K with a standard deviation of $ 17.65M.
The following table provides additional summary stats:
CF - Equity in the Market:
filtered constituents2.9K
min$ -60.59M
max$ 60.64M
average$ 130.54K
median$ 0
std$ 17.65M